A heterogeneous response to EZH2 inhibition in PDOs was observed, which correlated with H3K27me3 expression in both tumor organoids and matched patient tumors, demonstrating organoids’ capacity to maintain the original tumor’s epigenetic signatures. This evidence concerns the gene EZH2 and neoplasm.